DOSAGE & ADMINISTRATION SECTION.
DIRECTIONS. adults 65 years of age and older ask doctoradults and children 12-64 years of age take tablet (5 mg) once daily in the eveningdo not take more than1 tablet (5 mg) in 24 hours 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptomschildren 6-11 years of age take 1/2 tablet (2.5 mg) once daily in the eveningdo not take more than 1/2 tablet (2.5 mg) in 24 hourschildren under years of age do not useconsumers with kidney disease do not use. ask doctor. take tablet (5 mg) once daily in the evening. do not take more than1 tablet (5 mg) in 24 hours. 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms. take 1/2 tablet (2.5 mg) once daily in the evening. do not take more than 1/2 tablet (2.5 mg) in 24 hours. do not use. do not use.
Citing DrugCentral © 2023. License
INACTIVE INGREDIENT SECTION.
Inactive ingredients. hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, silicon dioxide, and titanium dioxide.
Citing DrugCentral © 2023. License
INDICATIONS & USAGE SECTION.
Uses. temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat. runny nose. sneezing. itchy, watery eyes. itching of the nose or throat.
Citing DrugCentral © 2023. License
OTC - ACTIVE INGREDIENT SECTION.
Active ingredient (in each tablet). Levocetirizine dihydrochloride USP mg.
Citing DrugCentral © 2023. License
OTC - ASK DOCTOR SECTION.
Ask doctor before use if you have. ever had trouble urinating or emptying your bladder. ever had trouble urinating or emptying your bladder.
Citing DrugCentral © 2023. License
OTC - ASK DOCTOR/PHARMACIST SECTION.
ASK DOCTOR OR PHARMACIST BEFORE USE IF.
Citing DrugCentral © 2023. License
OTC - DO NOT USE SECTION.
Do not use. if you have kidney disease if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine. if you have kidney disease if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine.
Citing DrugCentral © 2023. License
OTC - KEEP OUT OF REACH OF CHILDREN SECTION.
Keep out of reach of children.. In case of overdose, get medical help or contact Poison Control Center right away (1-800-222-1222).
Citing DrugCentral © 2023. License
OTC - PREGNANCY OR BREAST FEEDING SECTION.
If pregnant or breast-feeding:. if breast-feeding: not recommended if pregnant: ask health professional before use. if breast-feeding: not recommended. if pregnant: ask health professional before use.
Citing DrugCentral © 2023. License
OTC - PURPOSE SECTION.
Purpose. Antihistamine.
Citing DrugCentral © 2023. License
OTC - STOP USE SECTION.
Stop use and ask doctor if. you have trouble urinating or emptying your bladder an allergic reaction to this product occurs. Seek medical help right away.. you have trouble urinating or emptying your bladder. an allergic reaction to this product occurs. Seek medical help right away.
Citing DrugCentral © 2023. License
OTC - WHEN USING SECTION.
When using this product. drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving motor vehicle or operating machinery. drowsiness may occur. avoid alcoholic drinks. alcohol, sedatives, and tranquilizers may increase drowsiness. be careful when driving motor vehicle or operating machinery.
Citing DrugCentral © 2023. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
PRINCIPAL DISPLAY PANEL. MICRO LABS LIMITED Container NDC- 42571-312-90 Levocetirizine dihydrochloride Tablets USP 5mg Antihistamine 90 Tablets MICRO LABS Container-Carton NDC- 42571-312-90 Levocetirizine dihydrochloride Tablets USP 5mg Antihistamine 90 Tablets MICRO LABS INVATECH PHARMA SOLUTIONS LLC Container NDC- 42571-312-90 Levocetirizine dihydrochloride Tablets USP 5mg Antihistamine 90 Tablets MICRO LABS Container-Carton NDC- 42571-312-90 Levocetirizine dihydrochloride Tablets USP 5mg Antihistamine 90 Tablets MICRO LABS micro container label. micro carton label. invatech container label. invatech carton label.
Citing DrugCentral © 2023. License
SPL UNCLASSIFIED SECTION.
Questions or comments. call 1-855-839-8195.
Citing DrugCentral © 2023. License
STORAGE AND HANDLING SECTION.
STORAGE. store between 20 and 25C (68 and 77F) safety sealed: do not use if carton was opened or torn store between 20 and 25C (68 and 77F) safety sealed: do not use if carton was opened or torn.
Citing DrugCentral © 2023. License
WARNINGS SECTION.
WARNINGS. Do not use. if you have kidney disease if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine. if you have kidney disease if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine. Ask doctor before use if you have. ever had trouble urinating or emptying your bladder. ever had trouble urinating or emptying your bladder. When using this product. drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving motor vehicle or operating machinery. drowsiness may occur. avoid alcoholic drinks. alcohol, sedatives, and tranquilizers may increase drowsiness. be careful when driving motor vehicle or operating machinery. Stop use and ask doctor if. you have trouble urinating or emptying your bladder an allergic reaction to this product occurs. Seek medical help right away.. you have trouble urinating or emptying your bladder. an allergic reaction to this product occurs. Seek medical help right away.. If pregnant or breast-feeding:. if breast-feeding: not recommended if pregnant: ask health professional before use. if breast-feeding: not recommended. if pregnant: ask health professional before use. Keep out of reach of children.. In case of overdose, get medical help or contact Poison Control Center right away (1-800-222-1222).
Citing DrugCentral © 2023. License